**Question:** A 9 year old girl was admitted for dialysis. On laboratory examination her potassium levels were 7.8 mEq/L. Which of the following would quickly lower her increased potassium levels-

A. Hemodialysis
B. Insulin
C. Potassium-binding resin
D. Calcium gluconate

**Correct Answer:** .

**Core Concept:** Management of hyperkalemia (high potassium levels) in a pediatric patient.

**Why the Correct Answer is Right:**

The correct answer, C. Potassium-binding resin, belongs to a class of medications called potassium-sparing agents, which are used to lower potassium levels in patients with hyperkalemia. Potassium-binding resins work by forming insoluble complexes with excess potassium in the gastrointestinal tract, preventing its absorption and thus reducing blood potassium levels. In this case, hemodialysis is not a suitable option as it is a treatment for acute kidney failure rather than a medication for hyperkalemia. Insulin is used to lower blood glucose levels and is not effective in managing hyperkalemia. Calcium gluconate is a calcium supplement that would instead increase potassium levels and exacerbate the patient's condition.

**Why Each Wrong Option is Incorrect:**

A. Hemodialysis: Although essential for kidney failure management, hemodialysis is not a medication, but a treatment procedure. It is not indicated for acute management of hyperkalemia.

B. Insulin: Insulin is a hypoglycemic agent used to lower blood glucose levels. It does not have any effect on hyperkalemia management.

C. Potassium-binding resin (e.g., Sodium Polystyrene Sulfonate): This is a medication specifically designed to lower potassium levels in patients with hyperkalemia. It works by reducing potassium absorption in the gastrointestinal tract, thereby decreasing potassium levels in the blood.

D. Calcium gluconate: Calcium gluconate is a calcium supplement that would increase serum calcium levels and worsen the potassium imbalance, making it an inappropriate choice for hyperkalemia management.

**Clinical Pearl:**

In pediatric patients with hyperkalemia, it is crucial to identify the underlying cause and consider medications like potassium-binding resins (e.g., Sodium Polystyrene Sulfonate) as the first choice for reducing serum potassium levels. Hemodialysis is usually reserved for more severe cases when oral medications are ineffective or contraindicated. Insulin is not effective in reducing potassium levels. Calcium gluconate should be avoided due to its potential to worsen hyperkalemia by increasing serum calcium levels.